Discover Syntara’s latest Phase 2a trial results for amsulostat in myelofibrosis, showing breakthrough symptom relief and strong pipeline updates.
As students panic about Pepperdine's ranking, what are lists like U.S. News really evaluating? In a letter to the editor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback